Mirror Now
@mirrornow·2.2M subscribers·145K videos
Concerns over Covaxin efficacy result in low turnout for COVID vaccination
Posted
January 20, 2021
Views
206
Likes
5
Engagement
2.43%
January 20, 2021
206
5
2.43%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
15:16Now PlayingIndia has kicked off the world’s largest COVID vaccination drive, however, there seems to be a wave of hesitancy involved over the safety and efficacy of Covaxin, developed by biotechnology firm Bharat Biotech and the Indian Council of Medical Research, which has led to fewer people turning up for their shots. The death of a few healthcare workers after receiving the jab may have raised concerns. The government is urging citizens not to worry and get the vaccine. India began its vaccination drive for frontline and healthcare workers on January 16, and has inoculated 631,417 people in four days so far.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
